Valneva reports positive phase-III results for inactivated, adjuvanted COVID-19 vaccine candidate VLA2001 Read more
Sacituzumab Govitecan receives positive CHMP opinion as 2L treatment for adult patients with metastatic triple-negative breast cancer Read more